PARP1 and rhabdoid tumor: Moreover, the PARP inhibitor Rucaparib is moderately effective at decreasing colony formation and growth of atypical teratoid rhabdoid tumors in xenograft mouse models, but treatment with this agent sensitizes cells to radiation and the combination of Rucaparib and radiation extends mouse survival [61].